The Effect of Smoking and Opioid Consumption on the Severity of the Disease and Duration of Hospitalization in COVID-19 Patients

1. Halaji M, Heiat M, Faraji N, Ranjbar R. Epidemiology of COVID-19: An updated review. J Res Med Sci [Internet]. 30 September 2021;26:82. Available at: https://pubmed.ncbi.nlm.nih.gov/34759999Search in Google Scholar

2. Hardenbrook NJ, Zhang P. A structural view of the SARS-CoV-2 virus and its assembly. Curr Opin Virol. 2022;52:123–34.Search in Google Scholar

3. Samavati L, Uhal BD. ACE2, Much More Than Just a Receptor for SARS-COV-2. Vol 10, Frontiers in Cellular and Infection Microbiology. 2020.Search in Google Scholar

4. Zeinali T, Faraji N, Joukar F et al. Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm. Microb Pathog [Internet]. 2022;105704. Available at: https://www.sciencedirect.com/science/article/pii/S0882401022003175Search in Google Scholar

5. Anastassopoulou C, Gkizarioti Z, Patrinos GP, Tsakris A. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genomics [Internet]. 2020;14(1):40. Available at: https://doi.org/10.1186/s40246-020-00290-4Search in Google Scholar

6. Yaghubi T, Shakoori V, Nasiri S et al. Clinical characteristics and outcomes of COVID-19 patients with a history of cardiovascular disease. J Curr Biomed Reports. 2022.Search in Google Scholar

7. Reddy RK, Charles WN, Sklavounos A et al. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. J Med Virol. Februarie 2021;93(2):1045-56.Search in Google Scholar

8. Eastin C, Eastin T. Clinical Characteristics of Coronavirus Disease 2019 in China: Guan W, Ni Z, Hu Y, et al. N Engl J Med. 2020 Feb 28 [Online ahead of print] DOI: 10.1056/NEJMoa2002032. J Emerg Med [Internet]. 2020/06/03. April 2020;58(4):711-2. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266766/Search in Google Scholar

9. Rossato M, Russo L, Mazzocut S et al. Current smoking is not associated with COVID-19. The European respiratory journal. 2020, 55.Search in Google Scholar

10. Hopkinson NS, Rossi N, El-Sayed Moustafa J et al. Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people. Thorax. Julie 2021;76(7):714-22.Search in Google Scholar

11. Yu X, Sun X, Cui P et al. Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China. Transbound Emerg Dis. Julie 2020;67(4):1697–707.Search in Google Scholar

12. Gülsen A, Yigitbas BA, Uslu B et al. The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis. Pulm Med [Internet]. 08 September 2020;2020:7590207. Available at: https://pubmed.ncbi.nlm.nih.gov/32963831Search in Google Scholar

13. Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med. 2020;75:107–8.Search in Google Scholar

14. West R. Tobacco smoking: Health impact, prevalence, correlates and interventions. Psychol Health. 2017/05/28. Augustus 2017;32(8):1018–36.Search in Google Scholar

15. Strzelak A, Ratajczak A, Adamiec A, Feleszko W. Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review. Int J Environ Res Public Health. Mei 2018;15(5).Search in Google Scholar

16. Liu W, Tao Z-W, Wang L et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). Mei 2020;133(9):1032-8.Search in Google Scholar

17. Alqahtani JS, Aldhahir AM, Oyelade T et al. Smoking cessation during COVID-19: the top to-do list. NPJ Prim care Respir Med. Mei 2021;31(1):22.Search in Google Scholar

18. Ho KS, Narasimhan B, Sheehan J et al. Controversy over smoking in COVID-19-A real world experience in New York city. J Med Virol. Julie 2021;93(7):4537–43.Search in Google Scholar

19. Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. Junie 2021;116(6):1319–68.Search in Google Scholar

20. Usman MS, Siddiqi TJ, Khan MS et al. Is there a smoker’s paradox in COVID-19? BMJ evidence-based Med. Desember 2021;26(6):279–84.Search in Google Scholar

21. Khalili P, Ayoobi F, Mohamadi M et al. Effect of opium consumption on cardiovascular diseases – a cross-sectional study based on data of Rafsanjan cohort study. BMC Cardiovasc Disord [Internet]. 2021;21(1):2. Available at: https://doi. org/10.1186/s12872-020-01788-4Search in Google Scholar

22. Mehrabi S, Delavari A, Moradi G et al. Smoking among 15- to 64-Year-Old Iranian People in 2005. irje [Internet]. 01 September 2007;3(1):1–9. Available at: http://irje.tums.ac.ir/article-1-165-en.htmlSearch in Google Scholar

23. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 15 Februarie 2020;395(10223):497–506. Available at: https://doi.org/10.1016/S0140-6736(20)30183-5Search in Google Scholar

24. Chen Q, Zheng Z, Zhang C et al. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection [Internet]. 2020/04/28. Augustus 2020;48(4):543–51. Available at: https://pubmed.ncbi. nlm.nih.gov/32342479Search in Google Scholar

25. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). Maart 2020;395(10229):1054–62.Search in Google Scholar

26. Alqahtani JS, Oyelade T, Aldhahir AM et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147.Search in Google Scholar

27. Samet JM. Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19. Nicotine Tob Res [Internet]. 01 Desember 2020;22(Supplement_1):S93–5. Available at: https://doi.org/10.1093/ntr/ntaa187Search in Google Scholar

28. Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. Augustus 2020;15(5):845–52.Search in Google Scholar

29. Zureik M, Baricault B, Vabre C et al. Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France. medRxiv [Internet]. 01 Januarie 2020;2020.07.28.20160630. Available at: http://medrxiv.org/content/early/2020/07/30/2020.07.28.20160630.abstractSearch in Google Scholar

30. Farsalinos K, Niaura R, Le Houezec J et al. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicology reports. 2020,7,658-63.Search in Google Scholar

31. Oakes JM, Fuchs RM, Gardner JD et al. Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. November 2018;315(5):R895-906.Search in Google Scholar

32. Yue X, Basting TM, Flanagan TW et al. Nicotine Downregulates the Compensatory Angiotensin-Converting Enzyme 2/Angiotensin Type 2 Receptor of the Renin–Angiotensin System. Annal Am Thorac Soc, 2018;15, bl S126-7.Search in Google Scholar

33. Qeadan F, Mensah NA, Tingey B et al. The association between opioids, environmental, demographic, and socioeconomic indicators and COVID-19 mortality rates in the United States: an ecological study at the county level. Arch Public Heal [Internet]. 2021;79(1):101. Available at: https://doi. org/10.1186/s13690-021-00626-zSearch in Google Scholar

34. Riahi T, Sadeghzadeh-Bazargan A, Shokri S et al. The effect of opium on severity of COVID-19 infection:An original study from Iran. Med J Islam Repub Iran. 2021;35:115.Search in Google Scholar

35. Chadzinska M, Kolaczkowska E, Seljelid R, Plytycz B. Morphine modulation of peritoneal inflammation in Atlantic salmon and CB6 mice. J Leukoc Biol [Internet]. 01 Mei 1999;65(5):590-6. Available at: https://doi.org/10.1002/jlb.65.5.590Search in Google Scholar

36. Roy S, Loh HH. Effects of opioids on the immune system. Neurochem Res. November 1996;21(11):1375-86.Search in Google Scholar

37. Dolati-Somarin A, Abd-Nikfarjam B. The Reasons for Higher Mortality Rate in Opium Addicted Patients with COVID-19: A Narrative Review. Iran J Public Health. Maart 2021;50(3):470-9.Search in Google Scholar

38. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am. Maart 1992;76(2):333–53.Search in Google Scholar

39. Fang X, Li S, Yu H et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY) [Internet]. 2020/07/13. 13 Julie 2020;12(13):12493–503. Available at: https://pubmed.ncbi.nlm.nih.gov/32658868Search in Google Scholar